Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sigilon Therapeutics Inc.

    NASDAQ: SGTX · Real-Time Price · USD
    22.47
    -0.59 (-2.56%)
    At close: Aug 10, 2023, 10:00 PM

    Sigilon Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -43.56M -77.31M
    Depreciation & Amortization
    		 1.26M 1.12M
    Stock-Based Compensation
    		 5.9M 6.15M
    Other Working Capital
    		 -15.92M -9.41M
    Other Non-Cash Items
    		 4.19M 5.06M
    Deferred Income Tax
    		 n/a 3K
    Change in Working Capital
    		 -19.27M -13.42M
    Operating Cash Flow
    		 -51.47M -78.41M
    Capital Expenditures
    		 -537K -1.83M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 -42.52M -16.23M
    Sales Maturities Of Investments
    		 30.75M n/a
    Other Investing Acitivies
    		 230K n/a
    Investing Cash Flow
    		 -12.08M -18.06M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a -622K
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 -1.61M 1.55M
    Financial Cash Flow
    		 -1.61M 1.55M
    Net Cash Flow
    		 -65.16M -94.91M
    Free Cash Flow
    		 -52.01M -80.24M

    Add to Watchlist